Contact

All Stories

  1. Medical Applications of Molecular Biotechnologies in the Context of Hashimoto’s Thyroiditis

    Article • Diagnostics, June 2023, MDPI AG

    MD, PhD maria trovato

  2. Medical Applications of Molecular Biotechnologies in the Context of the Hashimoto’s Thyroiditis

    Article • April 2023, MDPI AG

    MD, PhD maria trovato

  3. Update on International Medical Taxonomies of Biomarkers and Their Applications in Management of Thyroid Cancers

    Article • Diagnostics, March 2022, MDPI AG

    MD, PhD maria trovato

  4. Interleukin‑6 signalling as a valuable cornerstone for molecular medicine (Review)

    Article • International Journal of Molecular Medicine, April 2021, Spandidos Publications

    MD, PhD maria trovato

  5. A historical excursus of diagnostic methods for Hashimoto thyroiditis and Graves' disease

    Article • Gazzetta Medica Italiana Archivio per le Scienze Mediche, September 2020, Edizioni Minerva Medica

    MD, PhD maria trovato

  6. Around the human voice: the anatomical path of the phonetic organ. A story of functional evidence and theoretical hypothesis

    Article • Otorinolaringologia, November 2018, Edizioni Minerva Medica

    MD, PhD maria trovato

  7. Nanostructures: between natural environment and medical practice

    Article • Reviews on Environmental Health, September 2018, De Gruyter

    MD, PhD maria trovato

  8. Classic and trans-signaling IL-6 in Hashimoto’s thyroiditis and HIV+

    Article • Immunobiology, March 2018, Elsevier

    MD, PhD maria trovato

  9. Coexistence of diffuse large B-cell lymphoma and papillary thyroid carcinoma in a patient affected by Hashimoto's thyroiditis

    Article • Archives of Endocrinology and Metabolism, December 2017, Archives of Endocrinology and Metabolism

    MD, PhD maria trovato

  10. Comparative analysis of diagnostic performance, feasibility and cost of different test-methods for thyroid nodules with indeterminate cytology

    Article • Oncotarget, April 2017, Impact Journals, LLC

    MD, PhD maria trovato

  11. Thyroid cancer and HGF/cmet system

    Article • Biomarker Insights, January 2017, SAGE Publications

    MD, PhD maria trovato

  12. Combined clinical and ultrasound follow-up assists in malignancy detection in Galectin-3 negative Thy-3 thyroid nodules

    Article • Endocrine, October 2015, Springer Science + Business Media

    MD, PhD maria trovato

  13. Thyroid hemiagenesis, Graves’ disease and differentiated thyroid cancer: a very rare association: case report and review of literature

    Article • HORMONES, July 2015, Springer Science + Business Media

    MD, PhD maria trovato

  14. TP53 polymorphism may contribute to genetic susceptibility to develop Hashimoto’s thyroiditis

    Article • Journal of Endocrinological Investigation, May 2015, Springer Science + Business Media

    MD, PhD maria trovato

  15. HGF/c-met system targeting PI3K/AKT and STAT3/phosphorylated-STAT3 pathways in pituitary adenomas: an immunohistochemical characterization in view of targeted therapies

    Article • Endocrine, April 2013, Springer Science + Business Media

    MD, PhD maria trovato

  16. The Loss of the p53 Activator HIPK2 Is Responsible for Galectin-3 Overexpression in Well Differentiated Thyroid Carcinomas

    Article • PLoS ONE, June 2011, PLOS

    MD, PhD maria trovato

  17. The tyrosine kinase receptor c-met, its cognate ligand HGF and the tyrosine kinase receptor trasducers STAT3, PI3K and RHO in thyroid nodules associated with Hashimoto's thyroiditis: an immunohistochemical characterization

    Article • European Journal of Histochemistry, June 2010, PAGEPress Publications

    MD, PhD maria trovato

  18. Immunoexpression of CD30 and CD30 ligand in deciduas from spontaneous abortions

    Article • European Journal of Histochemistry, June 2009, PAGEPress Publications

    MD, PhD maria trovato

  19. Serum hepatocyte growth factor is increased in Hashimoto’s thyroiditis whether or not it is associated with nodular goiter as compared with healthy non-goitrous individuals

    Article • Journal of Endocrinological Investigation, March 2009, Springer Science + Business Media

    MD, PhD maria trovato

  20. Frizzled‐1 is down‐regulated in follicular thyroid tumours and modulates growth and invasiveness

    Article • The Journal of Pathology, February 2008, Wiley

    MD, PhD maria trovato

  21. What is New on Thyroid Cancer Biomarkers

    Article • Biomarker Insights, January 2008, SAGE Publications

    MD, PhD maria trovato

  22. Expression of p53/hgf/c-met/STAT3 signal in fetuses with neural tube defects

    Article • Virchows Archiv, January 2007, Springer Science + Business Media

    MD, PhD maria trovato

  23. Lack of Somatostatin Analogs Effectiveness in Gonadotropin-Secreting Pituitary Adenomas

    Article • The Endocrinologist, July 2006, Wolters Kluwer Health

    MD, PhD maria trovato

  24. Repression of the Antiapoptotic Molecule Galectin-3 by Homeodomain-Interacting Protein Kinase 2-Activated p53 Is Required for p53-Induced Apoptosis

    Article • Molecular and Cellular Biology, June 2006, ASM Journals

    MD, PhD maria trovato

  25. Clinico-pathological significance of cell-type-specific loss of heterozygosity on chromosome 7q21: analysis of 318 microdissected thyroid lesions.

    Article • Endocrine Related Cancer, June 2004, Bioscientifica

    MD, PhD maria trovato

  26. Co-expression of interleukin-6 (IL-6) and interleukin-6 receptor (IL-6R) in thyroid nodules is associated with co-expression of CD30 ligand/CD30 receptor

    Article • Journal of Endocrinological Investigation, December 2002, Springer Science + Business Media

    MD, PhD maria trovato

  27. Expression of CD30 Ligand and CD30 Receptor in Normal Thyroid and Benign and Malignant Thyroid Nodules

    Article • Thyroid, July 2001, Mary Ann Liebert Inc

    MD, PhD maria trovato

  28. Loss of Heterozygosity of the Long Arm of Chromosome 7 in Follicular and Anaplastic Thyroid Cancer, but Not in Papillary Thyroid Cancer1

    Article • The Journal of Clinical Endocrinology & Metabolism, September 1999, Endocrine Society

    MD, PhD maria trovato

  29. Expression of the Hepatocyte Growth Factor and c-met in Normal Thyroid, Non-neoplastic, and Neoplastic Nodules

    Article • Thyroid, February 1998, Mary Ann Liebert Inc

    MD, PhD maria trovato